Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1990
10/10/1990CA2011826A1 Film-forming emulsion containing iodine and methods of use
10/09/1990USRE33375 Treatments employing drug-containing matrices for introduction into cellular lesion areas
10/09/1990US4962188 Recombinant ricin toxin A chain conjugates
10/09/1990US4962170 Method of making highly absorptive polymers
10/09/1990US4962091 Controlled release of macromolecular polypeptides
10/09/1990US4962048 For binding to membranes surrounding tumors; hybridom cell lines
10/09/1990US4961927 Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
10/09/1990US4961922 Complexes based on anthralin and a sterol, a process for obtaining them and their use in therapeutics and cosmetics
10/09/1990CA1275045A1 Drug carrier and pharmaceutical preparation comprising the same
10/09/1990CA1275042A1 Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
10/08/1990WO1990012050A1 Chelants
10/08/1990CA2051648A1 Chelants
10/07/1990CA2014103A1 Interleukin-1 formulation
10/07/1990CA2014010A1 Surface treatment for zinciferous surfaces
10/06/1990WO1990011782A2 Immunoconjugates and prodrugs and their use in association for drug delivery
10/06/1990CA2030564A1 Immunoconjugates and prodrugs and their use in association for drug delivery
10/04/1990WO1990011783A1 Platelet specific immunoconjugates
10/04/1990WO1990011092A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990WO1990011079A1 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
10/04/1990WO1990011077A1 Spironolactone composition
10/04/1990WO1990011069A1 Process for the preparation of a ligand-receptor complex
10/04/1990WO1990011064A1 Skin permeation enhancer compositions
10/04/1990WO1990011017A1 A moderated spun fibrous system and method of manuacture
10/04/1990WO1990011014A1 Topical analgesic composition
10/04/1990CA2489769A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990CA2357538A1 Expression of exogenous polynucleotide sequences in a vertebrate
10/04/1990CA2051436A1 Platelet specific immunoconjugates
10/04/1990CA2013770A1 Use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
10/04/1990CA2013600A1 Pharmaceutical formulations
10/03/1990EP0390574A2 Compositions of phytic acid, and pharmaceutical uses thereof
10/03/1990EP0390541A2 Paste-like base and preparation
10/03/1990EP0390435A1 Vitamin B group compound composition and its production
10/03/1990EP0390369A2 Orally administrable ibuprofen compositions
10/03/1990EP0390206A2 Stable perfluoropolyether emulsions
10/03/1990EP0390071A1 Preservative system for ophthalmic formulations
10/03/1990EP0389982A2 Anti-peptic ulcer agent
10/03/1990EP0389773A2 Process for preparing a galenic formulation of 2-hydroxy-5-methyllaurophenonoxime with optimal bioavailability
10/03/1990CA2013580A1 Method for enhancing transmembrane transport of exogenous molecules
10/03/1990CA2013134A1 Destructurized starch and method of making same
10/02/1990US4960866 Phase separation, precipitation, recovering
10/02/1990US4960771 Oxazolidinone penetration enhancing compounds
10/02/1990US4960763 Method of using bacterial cellulose as a dietary fiber component
10/02/1990US4960596 Acid-free galenical preparation; capsules, pills or sachets for angina, hypertension, circulatory insufficiency
10/02/1990CA1274774A1 Method for administering insulin
10/01/1990WO1990011780A1 Preparation of liposome and lipid complex compositions
10/01/1990WO1990011753A1 Pharmaceutical lipid composition for parenteral nutrition
10/01/1990CA2050586A1 Pharmaceutical lipid composition for parenteral nutrition
09/1990
09/30/1990CA2013476A1 Paste-like base and preparation
09/29/1990CA2013225A1 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
09/28/1990WO1990011091A1 FORMULATIONS FOR STABILIZING OF IgM ANTIBODIES
09/28/1990CA2049342A1 Formulations for stabilizing of igm antibodies
09/27/1990CA2012912A1 Anti-peptic ulcer agent
09/26/1990EP0389386A1 Polyester-polysiloxane block copolymer degradable by hydrolysis
09/26/1990EP0389043A1 Production of modified PE40
09/26/1990EP0388914A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
09/26/1990EP0388817A2 Use of mixed micelles and mixed micelle solutions of immunomodulators
09/26/1990EP0388758A1 Protein-polycation conjugate
09/26/1990EP0388434A1 Differential delivery of therapeutic agents across the blood brain barrier
09/26/1990EP0229564B1 Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein
09/26/1990EP0217141B1 W/o creams containing 17-propionate-21-acetate
09/26/1990CN1045524A Drug-release controlling coating material for long acting formulations
09/25/1990US4959365 Topical compositions of lipophilic pharmaceuticals agents
09/25/1990US4959358 Drug administration
09/25/1990US4959219 Sustained release of pharmaceutical compositions, ion exchange resins
09/25/1990US4959217 Delayed/sustained release of macromolecules
09/25/1990US4959215 Ifosfamide-mesna lyophilizate and process for its preparation
09/25/1990US4959175 Solution for dialyses and use of peptides based on glycine for preparing it
09/25/1990CA1274472A1 Composition and method for producing prolonged pain relief
09/20/1990WO1990010699A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS
09/20/1990WO1990010692A1 Monoclonal antibody for use in detection and treatment of childhood leukemia
09/20/1990WO1990010457A1 Method of treating hiv infections using immunotoxins
09/20/1990WO1990010456A1 Fibroblast growth factor (fgf)-based stabilized compositions
09/19/1990EP0388306A2 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
09/19/1990EP0388220A2 Compositions for the sustained release of chlorhexidine
09/19/1990EP0387808A2 Compositions for the preparation of dosage-form active vitamins D3 and process for preparing stable dosage-form active vitamins D3 by using the same
09/19/1990EP0387782A2 Solid pharmaceutical preparations and process for their manufacture
09/19/1990EP0387739A1 Production method for natural red pigment
09/19/1990EP0387655A2 Stabilization of polyprenyl compound
09/19/1990EP0387647A2 High-dispersion pharmaceutical composition
09/19/1990CN1045394A Composition containing associated compounds of hyaluronic acid and process for preparing them
09/18/1990US4958009 Anti-human ovarian cancer immunotoxins and methods of use thereof
09/18/1990US4957922 Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
09/18/1990US4957908 Chitosan pyrithione as antimicrobial agent useful in personal care products
09/18/1990US4957745 Beads with metoprolol salt, cellulose ether membrane
09/18/1990US4957744 Cosmetics, pharmaceuticals, plastics for sanitary and surgical articles
09/18/1990US4957742 Method for promoting hair growth
09/18/1990US4957119 Active material in ethylene-vinyl acetate matrix
09/18/1990CA1274140A1 Injecting apparatus for emergency treatment
09/17/1990CA2012395A1 Topical analgesic composition
09/17/1990CA2011985A1 Stabilization of polyprenyl compound
09/14/1990WO1990010460A1 Method for reducing side effects of a drug
09/14/1990CA2055497A1 Method for reducing side effects of a drug
09/14/1990CA2012008A1 Production method for natural red pigment
09/13/1990CA2011943A1 Compositions for the preparation of dosage-form active vitamins d3 and process for preparing stable dosage-form active vitamins d3 by using the same
09/12/1990EP0387154A1 Aerosol compositions for the imaging, diagnosis and targetted therapy of inflamed and tumoral focuses
09/12/1990EP0386967A2 A drug-release controlling coating material for long acting formulations
09/12/1990EP0386960A2 Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
09/12/1990EP0386951A2 An improved diluent formulation for daptomycin
09/12/1990EP0386801A2 Slow-release pharmaceutical composition
09/12/1990EP0386757A2 Biodegradable poly(phosphoesters)